DXCM
DexCom, Inc.
NMS
$73.45
-1.42
(-1.90%)
Blow-off · +2.03σ
Hot zone
Grade B
132-Day TAO Zones
21 EMA
+1 ATR
+2 ATR
−2 ATR
—
O —
H —
L —
C —
—
—
Key statistics
Mkt cap
$28.3B
P/E ttm
31.5
Fwd P/E
23.9
Beta
1.40
Day range
$73.45
52w range
$56.72 – $76.35
Avg vol
5.2M
RSI(2)
44.1
ROE
35.6%
Net mgn
19.3%
FCF mgn
21.9%
Debt/Eq
0.47
Div yld
—
Sector
Healthcare
Industry
Medical Devices
Next earn
2026-07-29
Matrix setup grades
Long
—
score 9 · tech 9 / 80 · support 0 / 20
above KC1 lower, +2.02 ATR from EMA21 · no notable pattern
Short
B
score 40 · tech 40 / 80 · support 0 / 20
KC2 upper, +2.02 ATR from EMA21 · no notable pattern
- · KC2 upper stretch — standard mean-reversion tier
- · RSI hook from overbought (66)
- · Stochastic bear cross in overbought
Options · swing
See more →
CALL
$75
2026-07-17
$3.70
PUT
$75
2026-07-17
$4.95
Insider activity
See more →No Form 4 filings in the last 30 days.
Earnings
See more →- Last reported
- 2026-04-30
- EPS (act / est)
- 0.51 / 0.45
- Surprise
- +12.6%
- Next report
- 2026-07-29
About
DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems for the management of diabetes and metabolic health in the United States and internationally. The company offers Dexcom G7 and G7 15 Day, an integrated continuous glucose monitoring system; Dexcom G6, a CGM system; Dexcom ONE+ to repla…